Cerebral PET with [18FJ-2-fluoro-2-deoxy-D-glucose has been performed in four patients with neurofibromatosis type 1 (NF1) to assess the relation between cerebral metabolic activity, MRI, and the presence of neurological symptoms, including seizures, as well as mental and language retardation. Widespread hypometabolism occurred in three of the patients. The lesions on MRI, which were localised in the subcortical white matter and grey structures, had normal rates of glucose metabolism. This finding suggests that the abnormalities seen on MRI are not due to defective blood supply, localised oedema, or grey matter heterotopic foci as previously hypothesised. The presence of the hypometabolic areas seems to be inconsistently related to the occurrence of seizures and is not proportional to the degree of mental impairment. This study provides evidence of a widespread cerebral hypometabolism that is not related to the presence of MRI abnormalities; conversely normal metabolism was present in the areas with an abnormal 1RI signal.
Symptoms of cerebral involvement are often reported in neurofibromatosis type 1 (NF1). Seizures, sometimes drug resistant, are present in 3-8% of these patients,lA mental retardation in 3-8%,' 56 and learning disabilities in 30-60%.' 46 The reason for a higher incidence of seizures and cognitive impairment in patients with NF1 than in the general population is largely unexplained. Disorders of cortical architecture and the presence of cerebral heterotopias have also been reported. [7] [8] [9] The clinical relevance of these findings is still controversial, however, although it has been suggested that they might be related to the occurrence of mental retardation and epilepsy. 28 Imaging abnormalities of 16 In epileptic patients focal PET abnormalities can correlate with paroxysmal activity in the EEG and may coincide with morphological lesions on x ray CT or MRI. In some epileptic patients the presence of areas of abnormal metabolism identified with PET has been attributed to cytoarchitectural disorders and biochemical abnormalities undetectable by conventional imaging techniques.'7 Indeed the assessment of cerebral metabolism in patients with NF1 has the potential of showing focal cerebral abnormalities, characterised by metabolic changes, in regions that appear normal, as well as in those that are pathological in x ray CT or MRI studies. To our knowledge studies of cerebral metabolism with PET in patients with NF1 have not been reported. Thus we have evaluated the cerebral pattern of glucose utilisation in four patients presenting with NF1 to assess the relation between cerebral functional activity, morphological findings, and clinical presentation.
Patients and methods

PATIENTS
We examined four patients, in whom the diagnosis of NFI was based on the criteria indicated by the Consensus Development Conference,'8 and a control population of nine patients, age range 10-20 years. The nine control subjects were all examined by PET for diagnostic reasons and were all presenting with mild forms of various neurological disturbances; they were five epileptic patients, seizure free for at least six months, two with mild cognitive developmental disabilities, one with headache, and one with spinal amyotrophy; they were presenting either with normal MRI or with aspecific abnormalities on MRI such as mild enlargement of the subarachnoid spaces or ventricles. Permission for the study was issued by the ethics committee of the Institute H S Raffaele where the PET studies were performed. (fig 1) . the age of 8 years and 10 months showed a global cerebral hypometabolism with an involvement of the frontal, parietal, and temporal associative cortices, and the whole occipital lobe, including the calcarine cortex, bilaterally. The thalamus and cerebellar hemispheres were also hypometabolic (fig 2, fig 3) . Conversely, normal rCMRglc was detected in the globus pallidus and internal capsule, in which an increased MRI signal was seen ( fig  2) . An EEG performed during the PET examination showed spikes, polispikes, and slow waves bilaterally in the occipital areas. The child was being treated with carbamazepine and phenytoin.
Case 2 This patient was a boy aged 11 years and 3 months. The diagnosis of NFI was made at the age of 2 years and 10 months. x Ray CT at the age of 4 years and 4 months showed a bilateral enlargement of the optic nerves. Areas of decreased density were present bilaterally in the capsulolenticular regions. At the age of 5 years and 9 months two areas, round shapes of hyperintense signal were seen in T2 weighted MRI images in the capsulolenticular regions-about 1 8 cm in diameter in the right hemisphere and 2-5 cm in the left hemisphere-in paravermian white matter, and in the pontomesencephalic regions. Their presence was confirmed by further MRI studies performed at the ages of 8 years and 5 months, 10 years, and 11 years and 3 months. Visual field examinations and EEGs were always normal. His IQ, evaluated at the age of 10 years, was 49 (performance 61; verbal 46), and there was also a severe language delay. Examination by PET at the age of 11 years and 3 months showed a slight metabolic reduction in the frontal regions, more evident on the left. The hypometabolism was also present bilaterally in the parietal cortex and in the thalamus; it was normal in the capsulolenticular regions with abnormal MRI signals (fig 3) .
Case 3
This patient was a 15 year old girl. She was referred for evaluation at the age of 7 years.
Mental development was in the low normal range (IQ 89; performance 94, verbal 84). Cerebral x ray CT and EEG repeated at the age of 10 years were normal. At the age of 12 years an area, about 1 x 0-8 x 0-8 cm, of increased signal was found in the right splenium by T2 weighted MRI; small areas of increased signal were also detected in the internal capsule and striatum bilaterally, pons, and cerebellar white matter. These areas were unchanged at the age of 13 years and 6 months and 14 years and 6 months. Echo Doppler of the carotid arteries was normal. A PET study on this 15 year old patient showed global cerebral and cerebellar hypometabolism. The whole frontal, temporal, parietal, and occipital cortex, including the calcarine cortex, was bilaterally involved. For the subcortical structures only the thalamus showed a profoundly reduced metabolism, whereas the basal ganglia were almost within normal range. A normal metabolic activity was present in the areas with hyperintense signal on MRI (fig 3) . Case 4 The patient was a 20 year old man. At the age of 2 years and 6 months he presented with a prolonged febrile seizure after a coma lasting 12 hours. The diagnosis of NFl, suspected at this time, was confirmed at the age of 17 years. His IQ was not assessed but a global psychological evaluation indicated a mental development in the low normal range. At the age of 9 years and 6 months simple and complex partial seizures appeared and were not responsive to medical treatment. An EEG showed paroxysmal activity in the bifrontal areas and subsequently a right temporal focus. A slight enlargement of the right cerebral ventricle was shown by x ray CT and confirmed by MRI at the age of 18. At the age of 20 years PET indicated the presence of normal cerebral metabolism. The metabolism in the cerebellar hemispheres was slightly reduced (fig 3) . An EEG during PET examination indicated the presence of slow waves in the right temporal cortex. The patient was being treated with carbamazepine.
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